 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper   
127th MAINE LEGISLATURE  
 
SECOND REGULAR SESSION -2016  
 
Legislative Document  No. 1685  
S.P. 693  In Senate, March 29, 2016  
 
 
An Act To Clarify That Buprenorphine Is a Scheduled Drug  
 
(AFTER DEADLINE)  
 
 
 
 
Approved for introduction by a majority of the Legislative Council pursuant to Joint Rule 
205. 
Reference to the Committee on Criminal Justice and Public Safety suggested and ordered 
printed pursuant to Joint Rule 218.  
 
 
  
 HEATHER J.R. PRIEST  
 Secretary of the Senate  
 
Presented by President THIBODEAU of Waldo.  
Cosponsored by Senator: CUSHING of Penobscot.  
 
 

 
 Page 1 - 127LR2787(01 )-1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  17-A MRSA §1102, sub -§1, ¶I, as amended by PL 2015, c. 330, §1, is 2 
further amended to read:  3 
I.  Unless listed or described in another schedule, any compound, mixture or 4 
preparation cont aining narcotic drugs, including, but not limited to, the following 5 
narcotic drugs or their salts, isomers or salts of isomers: heroin (diacetylmorphine), 6 
methadone, methadone hydrochloride, levo -alpha -acetyl -methadol, or LAAM, 7 
pethidine, morphine, oxycodo ne, hydrocodone, hydromorphone, buprenorphine,  8 
fentanyl, acetylfentanyl and any methylfentanyl derivatives and opium;  9 
SUMMARY  10 
This bill provides that buprenorphine is a schedule W drug.  11 
 
